Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1016/j.rmed.2008.08.018 http://repositorio.unifesp.br/handle/11600/31264 |
Resumo: | Introduction: Pulmonary dynamic hyperinflation (DH) is an important factor limiting the physical capacity of patients with COPD. Inhaled bronchodilator should be able to reduce DH.Objective: To measure DH in COPD patients during upper limbs exercise tests with previous use of bronchodilator or placebo, and to evaluate the respiratory pattern to justify the dynamics of hyperinflation.Methods: Inspiratory capacity (IC) of 16 patients with COPD (age: 63 13 years; FEV(1) of 1.5 +/- 0.7 L-41 +/- 11% predicted) was measured before and after an incremental arm exercise test (diagonal technique) with randomly and double-blinded inhaled placebo or salbutamol. Results: Rest IC increased from 2.32 +/- 0.44 L to 2.54 +/- 0.39 L after inhalation of 400 mcg of salbutamol. (p = 0.0012). There was a decrease in the IC after a maximal incremental arm exercise test, 222 +/- 158 ml. (p = 0.001) with placebo use, but no change was seen after the salbutamol use: 104 +/- 205 ml (p = 0.41); 62% of the patients presented a 10% or more reduction in the IC after the exercise with placebo. There was a correlation between DH and lower FEV(1)/FVC (p = 0.0067), FEV, predicted (p = 0.0091) and IC% predicted (p = 0.043) and higher VO(2) ml/Kg/min % predicted (p = 0.05). Minute ventilation and respiratory rate were higher during the exercise with placebo (p = 0.002) whereas VE/MVV ratio was tower in the exercise after salbutamol (p > 0.05).Conclusion: We conclude that the use of bronchodilator increases the IC of patient with COPD and may help not to increase the DH during a maximal. exercise with the arms. (C) 2008 Elsevier B.V. All rights reserved. |
id |
UFSP_518db93698482cb22784afaeb6f185fc |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/31264 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise testsUpper limbs exerciseDynamic hyperinflationSalbutamolCOPDIntroduction: Pulmonary dynamic hyperinflation (DH) is an important factor limiting the physical capacity of patients with COPD. Inhaled bronchodilator should be able to reduce DH.Objective: To measure DH in COPD patients during upper limbs exercise tests with previous use of bronchodilator or placebo, and to evaluate the respiratory pattern to justify the dynamics of hyperinflation.Methods: Inspiratory capacity (IC) of 16 patients with COPD (age: 63 13 years; FEV(1) of 1.5 +/- 0.7 L-41 +/- 11% predicted) was measured before and after an incremental arm exercise test (diagonal technique) with randomly and double-blinded inhaled placebo or salbutamol. Results: Rest IC increased from 2.32 +/- 0.44 L to 2.54 +/- 0.39 L after inhalation of 400 mcg of salbutamol. (p = 0.0012). There was a decrease in the IC after a maximal incremental arm exercise test, 222 +/- 158 ml. (p = 0.001) with placebo use, but no change was seen after the salbutamol use: 104 +/- 205 ml (p = 0.41); 62% of the patients presented a 10% or more reduction in the IC after the exercise with placebo. There was a correlation between DH and lower FEV(1)/FVC (p = 0.0067), FEV, predicted (p = 0.0091) and IC% predicted (p = 0.043) and higher VO(2) ml/Kg/min % predicted (p = 0.05). Minute ventilation and respiratory rate were higher during the exercise with placebo (p = 0.002) whereas VE/MVV ratio was tower in the exercise after salbutamol (p > 0.05).Conclusion: We conclude that the use of bronchodilator increases the IC of patient with COPD and may help not to increase the DH during a maximal. exercise with the arms. (C) 2008 Elsevier B.V. All rights reserved.Universidade Federal de São Paulo, Pulm Rehabil Ctr, BR-04023062 São Paulo, BrazilAdventist Univ, São Paulo, BrazilUniv Guarulhos, São Paulo, BrazilUniversidade Federal de São Paulo, Pulm Rehabil Ctr, BR-04023062 São Paulo, BrazilWeb of ScienceW B Saunders Co LtdUniversidade Federal de São Paulo (UNIFESP)Adventist UnivUniv GuarulhosPorto, Elias Ferreira [UNIFESP]Castro, Antônio Adolfo Mattos de [UNIFESP]Nascimento, Oliver Augusto [UNIFESP]Oliveira, Rosangela C. [UNIFESP]Cardoso, Fábio [UNIFESP]Jardim, José Roberto [UNIFESP]2016-01-24T13:52:12Z2016-01-24T13:52:12Z2009-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion251-257application/pdfhttp://dx.doi.org/10.1016/j.rmed.2008.08.018Respiratory Medicine. London: W B Saunders Co Ltd, v. 103, n. 2, p. 251-257, 2009.10.1016/j.rmed.2008.08.018WOS000263187100014.pdf0954-6111http://repositorio.unifesp.br/handle/11600/31264WOS:000263187100014engRespiratory Medicineinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-31T05:22:20Zoai:repositorio.unifesp.br/:11600/31264Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-31T05:22:20Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests |
title |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests |
spellingShingle |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests Porto, Elias Ferreira [UNIFESP] Upper limbs exercise Dynamic hyperinflation Salbutamol COPD |
title_short |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests |
title_full |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests |
title_fullStr |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests |
title_full_unstemmed |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests |
title_sort |
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests |
author |
Porto, Elias Ferreira [UNIFESP] |
author_facet |
Porto, Elias Ferreira [UNIFESP] Castro, Antônio Adolfo Mattos de [UNIFESP] Nascimento, Oliver Augusto [UNIFESP] Oliveira, Rosangela C. [UNIFESP] Cardoso, Fábio [UNIFESP] Jardim, José Roberto [UNIFESP] |
author_role |
author |
author2 |
Castro, Antônio Adolfo Mattos de [UNIFESP] Nascimento, Oliver Augusto [UNIFESP] Oliveira, Rosangela C. [UNIFESP] Cardoso, Fábio [UNIFESP] Jardim, José Roberto [UNIFESP] |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Adventist Univ Univ Guarulhos |
dc.contributor.author.fl_str_mv |
Porto, Elias Ferreira [UNIFESP] Castro, Antônio Adolfo Mattos de [UNIFESP] Nascimento, Oliver Augusto [UNIFESP] Oliveira, Rosangela C. [UNIFESP] Cardoso, Fábio [UNIFESP] Jardim, José Roberto [UNIFESP] |
dc.subject.por.fl_str_mv |
Upper limbs exercise Dynamic hyperinflation Salbutamol COPD |
topic |
Upper limbs exercise Dynamic hyperinflation Salbutamol COPD |
description |
Introduction: Pulmonary dynamic hyperinflation (DH) is an important factor limiting the physical capacity of patients with COPD. Inhaled bronchodilator should be able to reduce DH.Objective: To measure DH in COPD patients during upper limbs exercise tests with previous use of bronchodilator or placebo, and to evaluate the respiratory pattern to justify the dynamics of hyperinflation.Methods: Inspiratory capacity (IC) of 16 patients with COPD (age: 63 13 years; FEV(1) of 1.5 +/- 0.7 L-41 +/- 11% predicted) was measured before and after an incremental arm exercise test (diagonal technique) with randomly and double-blinded inhaled placebo or salbutamol. Results: Rest IC increased from 2.32 +/- 0.44 L to 2.54 +/- 0.39 L after inhalation of 400 mcg of salbutamol. (p = 0.0012). There was a decrease in the IC after a maximal incremental arm exercise test, 222 +/- 158 ml. (p = 0.001) with placebo use, but no change was seen after the salbutamol use: 104 +/- 205 ml (p = 0.41); 62% of the patients presented a 10% or more reduction in the IC after the exercise with placebo. There was a correlation between DH and lower FEV(1)/FVC (p = 0.0067), FEV, predicted (p = 0.0091) and IC% predicted (p = 0.043) and higher VO(2) ml/Kg/min % predicted (p = 0.05). Minute ventilation and respiratory rate were higher during the exercise with placebo (p = 0.002) whereas VE/MVV ratio was tower in the exercise after salbutamol (p > 0.05).Conclusion: We conclude that the use of bronchodilator increases the IC of patient with COPD and may help not to increase the DH during a maximal. exercise with the arms. (C) 2008 Elsevier B.V. All rights reserved. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-02-01 2016-01-24T13:52:12Z 2016-01-24T13:52:12Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.rmed.2008.08.018 Respiratory Medicine. London: W B Saunders Co Ltd, v. 103, n. 2, p. 251-257, 2009. 10.1016/j.rmed.2008.08.018 WOS000263187100014.pdf 0954-6111 http://repositorio.unifesp.br/handle/11600/31264 WOS:000263187100014 |
url |
http://dx.doi.org/10.1016/j.rmed.2008.08.018 http://repositorio.unifesp.br/handle/11600/31264 |
identifier_str_mv |
Respiratory Medicine. London: W B Saunders Co Ltd, v. 103, n. 2, p. 251-257, 2009. 10.1016/j.rmed.2008.08.018 WOS000263187100014.pdf 0954-6111 WOS:000263187100014 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Respiratory Medicine |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
251-257 application/pdf |
dc.publisher.none.fl_str_mv |
W B Saunders Co Ltd |
publisher.none.fl_str_mv |
W B Saunders Co Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268379791360000 |